Barriers to viral load suppression among adolescents living with HIV on anti-retroviral therapy: a retrospective study in Tanga, Tanzania.

IF 2.1 4区 医学 Q3 INFECTIOUS DISEASES
Stella Emmanuel Mushy, Expeditho Mtisi, Simon Mkawe, Eric Mboggo, John Ndega, Khadija I Yahya-Malima, Denice Kamugunya, Edwin Samuel Kilimba, Boniface S Mlay, Aisa Muya, Frida Ngalesoni
{"title":"Barriers to viral load suppression among adolescents living with HIV on anti-retroviral therapy: a retrospective study in Tanga, Tanzania.","authors":"Stella Emmanuel Mushy, Expeditho Mtisi, Simon Mkawe, Eric Mboggo, John Ndega, Khadija I Yahya-Malima, Denice Kamugunya, Edwin Samuel Kilimba, Boniface S Mlay, Aisa Muya, Frida Ngalesoni","doi":"10.1186/s12981-024-00622-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite the decreased incidence of the human immunodeficiency virus (HIV) in Tanzania, the number of adolescents living with HIV is increasing. This study aimed to describe factors independently associated with viral load non-suppression among adolescents living with HIV (ALHIV) on ART in the Tanga region.</p><p><strong>Methods: </strong>We conducted a retrospective study of routinely collected data from ALHIV on ART from October 2018 to April 2022. We extracted data from the Care and Treatment Clinics form number 2 (CTC2) database that included age, sex, BMI, World Health Organization HIV clinical disease stage, marital status, ART duration, viral load suppression, facility level, and Dolutegravir (DTG)-based regimen. We did descriptive analysis using frequencies to describe the study participants' socio-demographic and clinical characteristics. The Cox proportional hazard regression model was used to identify factors associated with viral load non-suppression (VLS). Viral load non-suppression was defined as viral load ≥ 1000 copies/ml. A total of 4735 ALHIV on ART were extracted from CTC2, then 2485 were excluded (2186 missed viral load results, 246 were lost to follow-up, and 53 deaths).</p><p><strong>Results: </strong>2250 ALHIV on ART were tested for viral load, of whom 2216 (98.62%) adolescents were on first-line ART, and 2024 (89.96%) participants were virally suppressed, while 226 (10.04%) were virally non-suppressed. In addition, 2131 (94.71%) of participants were using a DTG-based regimen; of them, 1969 (92.40%) were virally suppressed. Not using a DTG-based regimen (HR: 9.36, 95% CI 3.41-15.31) and dispensary facility level (HR: 3.61, 95% CI 1.44-7.03) were independently associated with increased hazard for viral load non-suppression. In addition, adolescents aged between 15 and 19 years are less likely to be virally suppressed (HR: 0.55, 95% CI 0.30-0.99).</p><p><strong>Conclusions: </strong>The dispensary facility level and not using a DTG-based regimen were significantly associated with viral load non-suppression. HIV intervention strategies should ensure a DTG-based regimen utilization in all adolescents living with HIV, and techniques used by higher-level health facilities should be disseminated to lower-level facilities.</p>","PeriodicalId":7503,"journal":{"name":"AIDS Research and Therapy","volume":"21 1","pages":"35"},"PeriodicalIF":2.1000,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11112887/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS Research and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12981-024-00622-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Despite the decreased incidence of the human immunodeficiency virus (HIV) in Tanzania, the number of adolescents living with HIV is increasing. This study aimed to describe factors independently associated with viral load non-suppression among adolescents living with HIV (ALHIV) on ART in the Tanga region.

Methods: We conducted a retrospective study of routinely collected data from ALHIV on ART from October 2018 to April 2022. We extracted data from the Care and Treatment Clinics form number 2 (CTC2) database that included age, sex, BMI, World Health Organization HIV clinical disease stage, marital status, ART duration, viral load suppression, facility level, and Dolutegravir (DTG)-based regimen. We did descriptive analysis using frequencies to describe the study participants' socio-demographic and clinical characteristics. The Cox proportional hazard regression model was used to identify factors associated with viral load non-suppression (VLS). Viral load non-suppression was defined as viral load ≥ 1000 copies/ml. A total of 4735 ALHIV on ART were extracted from CTC2, then 2485 were excluded (2186 missed viral load results, 246 were lost to follow-up, and 53 deaths).

Results: 2250 ALHIV on ART were tested for viral load, of whom 2216 (98.62%) adolescents were on first-line ART, and 2024 (89.96%) participants were virally suppressed, while 226 (10.04%) were virally non-suppressed. In addition, 2131 (94.71%) of participants were using a DTG-based regimen; of them, 1969 (92.40%) were virally suppressed. Not using a DTG-based regimen (HR: 9.36, 95% CI 3.41-15.31) and dispensary facility level (HR: 3.61, 95% CI 1.44-7.03) were independently associated with increased hazard for viral load non-suppression. In addition, adolescents aged between 15 and 19 years are less likely to be virally suppressed (HR: 0.55, 95% CI 0.30-0.99).

Conclusions: The dispensary facility level and not using a DTG-based regimen were significantly associated with viral load non-suppression. HIV intervention strategies should ensure a DTG-based regimen utilization in all adolescents living with HIV, and techniques used by higher-level health facilities should be disseminated to lower-level facilities.

接受抗逆转录病毒疗法的青少年艾滋病毒感染者抑制病毒载量的障碍:在坦桑尼亚坦噶进行的一项回顾性研究。
背景:尽管坦桑尼亚的人类免疫缺陷病毒(HIV)发病率有所下降,但感染 HIV 的青少年人数却在不断增加。本研究旨在描述坦噶地区接受抗逆转录病毒疗法的艾滋病病毒感染青少年(ALHIV)中与病毒载量不抑制独立相关的因素:我们对 2018 年 10 月至 2022 年 4 月期间常规收集的接受抗逆转录病毒疗法的 ALHIV 数据进行了回顾性研究。我们从护理和治疗诊所第 2 号表格(CTC2)数据库中提取了数据,其中包括年龄、性别、体重指数、世界卫生组织艾滋病临床疾病分期、婚姻状况、抗逆转录病毒疗法持续时间、病毒载量抑制率、设施级别和基于多鲁替拉韦(DTG)的治疗方案。我们使用频率进行描述性分析,以描述研究参与者的社会人口学和临床特征。我们使用 Cox 比例危险回归模型来确定与病毒载量未抑制(VLS)相关的因素。病毒载量不抑制定义为病毒载量≥1000拷贝/毫升。结果:2250 名接受抗逆转录病毒疗法的 ALHIV 接受了病毒载量检测,其中 2216 名(98.62%)青少年接受了一线抗逆转录病毒疗法,2024 名(89.96%)参与者的病毒载量得到抑制,226 名(10.04%)参与者的病毒载量未得到抑制。此外,2131 人(94.71%)正在使用以 DTG 为基础的治疗方案,其中 1969 人(92.40%)的病毒已被抑制。未使用基于 DTG 的治疗方案(HR:9.36,95% CI 3.41-15.31)和药房设施水平(HR:3.61,95% CI 1.44-7.03)与病毒载量未被抑制的风险增加独立相关。此外,15 至 19 岁的青少年病毒载量抑制的可能性较低(HR:0.55,95% CI 0.30-0.99):结论:药房设施水平和未使用基于 DTG 的治疗方案与病毒载量未得到抑制有很大关系。艾滋病干预策略应确保所有感染艾滋病病毒的青少年都使用以DTG为基础的治疗方案,并应将较高级医疗机构使用的技术推广到较低级医疗机构。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
AIDS Research and Therapy
AIDS Research and Therapy INFECTIOUS DISEASES-
CiteScore
3.80
自引率
4.50%
发文量
51
审稿时长
16 weeks
期刊介绍: AIDS Research and Therapy publishes articles on basic science, translational, clinical, social, epidemiological, behavioral and educational sciences articles focused on the treatment and prevention of HIV/AIDS, and the search for the cure. The Journal publishes articles on novel and developing treatment strategies for AIDS as well as on the outcomes of established treatment strategies. Original research articles on animal models that form an essential part of the AIDS treatment research are also considered
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信